Скачать или смотреть Thjis Spoor from AzurRx Biopharma on CEO Money

And your host of CEO Money, Michael Yorba

This is John Vandermosten, Zacks’ Biotech Analyst, guest host of CEO Money. Today we have the CEO of AzurRx BioPharma, Thijs Spoor. The ticker is AZRX. The company IPOed in October 2016 and shortly after launched its Phase 2 trial for MS1819 for Exocrine Pancreatic Insufficiency. There is an interesting back story on the company: their lead product came out of the wine and cheese institute in France. This group called INRA found that a blue cheese was producing a yeast that was generating an even more interesting enzyme, providing the basis for AzurRx’s lead candidate.

Thjis Spoor, President - AzurRx Biopharma - Nasdaq:AZRX
For more information visit http://azurrx.com/